Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: Long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort

Diabetes and Vascular Disease Research

Volumn 12, Issue 1, 2015, Pages 23-32

  Ritsinger, Viveca ^a,b   Tanoglidi, Eleni ^c   Malmberg, Klas ^a   Näsman, Per ^d   Rydén, Lars ^a   Tenerz, Åke ^c   Norhammar, Anna ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Kronoberg County Council   (Sweden)

^c CENTRAL HOSPITAL   (Sweden)

^d ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

diabetes; impaired glucose tolerance; Myocardial infarction; oral glucose tolerance test; prognosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE; HEART FAILURE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PROGNOSIS; AGED; BLOOD; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HOSPITAL DISCHARGE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PREVALENCE; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; SURVIVAL; SWEDEN;

AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS; SWEDEN;

EID: 84916908631     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164114551746     Document Type: Article

References (30)

1. Brussels, Belgium: International Diabetes Federation ; 2013:
2. Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2007 ; 115: 114-126
3. Coutinho M, Gerstein HC, Wang Y, et al. The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999 ; 22: 233-240
4. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and non-cardiovascular diseases?. Diabetes Care. 2003 ; 26: 688-696
5. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013 ; 36: S67 - S74
6. De Mulder M, Oemrawsingh RM, Stam F, et al. Comparison of diagnostic criteria to detect undiagnosed diabetes in hyperglycaemic patients with acute coronary syndrome. Heart. 2012 ; 98: 37-41
7. Doerr R, Hoffmann U, Otter W, et al. Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography the Silent Diabetes Study. Diabetologia. 2011 ; 54: 2923-2930
8. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002 ; 359: 2140-2144
9. Bartnik M, Rydén L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: the Euro Heart Survey on diabetes and the heart. Eur Heart J. 2004 ; 25: 1880-1890
10. Hu DY, Pan CY, Yu JM. The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J. 2006 ; 27: 2573-2579
11. Bartnik M, Malmberg K, Norhammar A, et al. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J. 2004 ; 25: 1990-1997
12. Lenzen M, Rydén L, Ohrvik J, et al. Euro Heart Survey Investigators. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur Heart J. 2006 ; 27: 2969-2974
13. Tamita K, Katayama M, Takagi T, et al. Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction. Circ J. 2007 ; 71: 834-841
14. Bartnik M, Malmberg K, Hamsten A, et al. Abnormal glucose tolerance - a common risk factor in patients with acute myocardial infarction in comparison with population-based controls. J Intern Med. 2004 ; 256: 288-297
15. Acute myocardial infarction: pre-hospital and in-hospital managements. Eur Heart J. 1996 ; 17: 43-63
16. Jeppson J-O, Jerntorp P, Almër L-O, et al. Capillary blood on filter paper for determination of HbA1c by ion exchange chromatography. Diabetes Care. 1996 ; 19: 142-145
17. Hoelzel W, Weykamp C, Jeppson J-O, et al. on behalf of the IFCC Working Group on HbA1c Standardization. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan and Sweden: a method-comparison study. Clin Chem. 2004 ; 50: 166-174
18. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus (Report of the WHO Consultation). Geneva: World Health Organization, Department of Non communicable Disease Surveillance, 1999; http://www.staff.ncl.ac.uk/philip.home/who-dmc.htm
19. Eur Heart J. 2000 ; 21: 1502-1516
20. Walker AE, Robins M, Weinfeld FD. The national survey of stroke: clinical findings. Stroke. 1981 ; 12: I13 - I44
21. Mooy JM, Grootenhuis PA, de Vries H, et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia. 1996 ; 39: 298-305
22. Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010 ; 375: 2215-2222
23. World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation. Geneva: WHO, 2011, http://www.who.int/diabetes/publications/report-hba1c-2011.pdf
24. Ning F, Tuomilehto J, Pyörälä K, et al. Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range. Diabetes Care. 2010 ; 33: 2211-2216
25. Rydén L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013 ; 34: 3035-3087
26. Anderson RE, Brismar K, Ivert T. Only a minority of patients referred for elective coronary artery bypass surgery have risk factors diagnosed and treated according to established guidelines. Diab Vasc Dis Res. 2007 ; 4: 112-116
27. Knudsen EC, Seljeflot I, Abdelnoor M, et al. Abnormal glucose regulation in patients with acute ST-elevation myocardial infarction - a cohort study on 224 patients. Cardiovasc Diabetol. 2009 ; 8: 6
28. Wallander M, Malmberg K, Norhammar A, et al. Oral glucose tolerance test a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice - a report on repeated oral glucose tolerance tests from the GAMI study. Diabetes Care. 2008 ; 31: 36-38
29. Wallander M, Bartnik M, Efendic S, et al. Beta-cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study. Diabetologia. 2005 ; 48: 2229-2235
30. Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006 ; 333: 1091-1094